Literature DB >> 2450949

Limiting dilution comparison of the repertoires of high and low responder MHC-restricted T cells.

M Kojima1, K B Cease, G K Buckenmeyer, J A Berzofsky.   

Abstract

To approach the mechanism that determines Ir gene-controlled high or low responsiveness to whole proteins, such as sperm whale myoglobin (SWMb), we compared the repertoires of high and low responder haplotype-restricted T cells for different myoglobin epitopes by limiting dilution frequency analysis. Poisson analysis was performed using long-term limiting dilution cell lines of (B10.BR [low] X B10.D2[high])F1 T cells maintained on high or low responder APCs. The cell lines were tested with SWMb peptides and fragments for T cell repertoire fine specificities and Ia restrictions. The frequency of SWMb-specific F1 T cells responsive on B10.BR (H-2k) APCs was 2.5-3.6-fold lower than on B10.D2 (H-2d) APCs. Strikingly, all of the H-2k-restricted T cells used I-Ek as a restriction element, whereas both I-Ad- and I-Ed-restricted T cells were found among the H-2d-restricted lines. The I-Ad-restricted T cells were dominant, and the majority was specific for the synthetic peptide 102-118. T cells specific for peptide 132-146, dominant in association with I-Ed, were less frequent. However, no detectable H-2k-restricted T cells were specific for either of these peptides, but instead they were specific for fragment 1-55 or peptide 59-80. Fragment 1-55 also stimulated a similar number of H-2d-restricted T cells. Therefore, the low response of F1 T cells on H-2k-presenting cells may be due to the failure to see myoglobin plus I-Ak, in particular the immunodominant site around Glu 109, in contrast to the dominant response of high responder mice (both H-2d and H-2s) focused on the I-A molecule and the site around residue Glu 109. The I-E- low responder B10 strain also failed to respond to peptide 102-118, supporting the idea that the low responder status results from a limited repertoire lacking response to 102-118 plus I-A. In those strains that respond to the immunodominant site 102-118, the frequency of T cells in the repertoire specific for this site was always considerably greater than that for other sites. These results suggest that there is an important difference between immunodominant epitopes and minor epitopes and that Ir gene-controlled low responsiveness to a natural whole protein may be due primarily to the failure to respond to a single immunodominant site, even though a number of other epitopes can be recognized.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2450949      PMCID: PMC2188878          DOI: 10.1084/jem.167.3.1100

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  43 in total

1.  T-cell antigenic sites tend to be amphipathic structures.

Authors:  C DeLisi; J A Berzofsky
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

2.  The T lymphocyte response to cytochrome c. V. Determination of the minimal peptide size required for stimulation of T cell clones and assessment of the contribution of each residue beyond this size to antigenic potency.

Authors:  R H Schwartz; B S Fox; E Fraga; C Chen; B Singh
Journal:  J Immunol       Date:  1985-10       Impact factor: 5.422

3.  T-lymphocyte response to cytochrome c. I. Demonstration of a T-cell heteroclitic proliferative response and identification of a topographic antigenic determinant on pigeon cytochrome c whose immune recognition requires two complementing major histocompatibility complex-linked immune response genes.

Authors:  A M Solinger; M E Ultee; E Margoliash; R H Schwartz
Journal:  J Exp Med       Date:  1979-10-01       Impact factor: 14.307

4.  Binding of immunogenic peptides to Ia histocompatibility molecules.

Authors:  B P Babbitt; P M Allen; G Matsueda; E Haber; E R Unanue
Journal:  Nature       Date:  1985 Sep 26-Oct 2       Impact factor: 49.962

Review 5.  The complexity of structures involved in T-cell activation.

Authors:  J W Goodman; E E Sercarz
Journal:  Annu Rev Immunol       Date:  1983       Impact factor: 28.527

6.  The T lymphocyte response to cytochrome C. III. Relationship of the fine specificity of antigen recognition to major histocompatibility complex genotype.

Authors:  L A Matis; S M Hedrick; C Hannum; M E Ultee; D Lebwohl; E Margoliash; A M Solinger; E A Lerner; R H Schwartz
Journal:  J Immunol       Date:  1982-06       Impact factor: 5.422

7.  Genetic control of the immune response to mammalian myoglobins in mice I. More than one I-region gene in H-2 controls the antibody response.

Authors:  J A Berzofsky
Journal:  J Immunol       Date:  1978-02       Impact factor: 5.422

8.  Distinct recognition phenotypes exist for T cell clones specific for small peptide regions of proteins. Implications for the mechanisms underlying major histocompatibility complex-restricted antigen recognition and clonal deletion models of immune response gene defects.

Authors:  N Shastri; A Oki; A Miller; E E Sercarz
Journal:  J Exp Med       Date:  1985-07-01       Impact factor: 14.307

9.  Genetic control of the immune response to staphylococcal nuclease. III. Time-course and correlation between the response to native nuclease and the response to its polypeptide fragments.

Authors:  J A Berzofsky; A N Schechter; G M Shearer; D H Sachs
Journal:  J Exp Med       Date:  1977-01-01       Impact factor: 14.307

10.  Genetic control of the immune response to staphylococcal nuclease. IV. H-2-linked control of the relative proportions of antibodies produced to different determinants of native nuclease.

Authors:  J A Berzofsky; A N Schechter; G M Shearer; D H Sachs
Journal:  J Exp Med       Date:  1977-01-01       Impact factor: 14.307

View more
  9 in total

1.  Identification of eight determinants in the hemagglutinin molecule of influenza virus A/PR/8/34 (H1N1) which are recognized by class II-restricted T cells from BALB/c mice.

Authors:  W Gerhard; A M Haberman; P A Scherle; A H Taylor; G Palladino; A J Caton
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

2.  High cell surface expression of CD4 allows distinction of CD4(+)CD25(+) antigen-specific effector T cells from CD4(+)CD25(+) regulatory T cells in murine experimental autoimmune encephalomyelitis.

Authors:  Jinzhu Li; William Ridgway; C Garrison Fathman; Harley Y Tse; Michael K Shaw
Journal:  J Neuroimmunol       Date:  2007-10-24       Impact factor: 3.478

3.  MHC class II restricted recognition of FMDV peptides by bovine T cells.

Authors:  E J Glass; R A Oliver; T Collen; T R Doel; R Dimarchi; R L Spooner
Journal:  Immunology       Date:  1991-12       Impact factor: 7.397

Review 4.  Structural basis of antigen recognition by T lymphocytes. Implications for vaccines.

Authors:  J A Berzofsky
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

5.  Induction of effective cross-reactive immunity by FMDV peptides is critically dependent upon specific MHC-peptide-T cell interactions.

Authors:  E J Glass; P Millar
Journal:  Immunology       Date:  1994-05       Impact factor: 7.397

6.  pH dependence and exchange of high and low responder peptides binding to a class II MHC molecule.

Authors:  P A Reay; D A Wettstein; M M Davis
Journal:  EMBO J       Date:  1992-08       Impact factor: 11.598

7.  T cell receptor (TCR)-mediated repertoire selection and loss of TCR vbeta diversity during the initiation of a CD4(+) T cell response in vivo.

Authors:  M Fassò; N Anandasabapathy; F Crawford; J Kappler; C G Fathman; W M Ridgway
Journal:  J Exp Med       Date:  2000-12-18       Impact factor: 14.307

8.  Influences of antigen processing on the expression of the T cell repertoire. Evidence for MHC-specific hindering structures on the products of processing.

Authors:  S J Brett; K B Cease; J A Berzofsky
Journal:  J Exp Med       Date:  1988-07-01       Impact factor: 14.307

9.  Association between human leukocyte antigen class II and pulmonary tuberculosis due to mycobacterium tuberculosis in Uganda.

Authors:  Dan Wamala; Helen Koyokoyo Buteme; Samuel Kirimunda; Gunilla Kallenius; Moses Joloba
Journal:  BMC Infect Dis       Date:  2016-01-23       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.